Susan M. Molineaux's Insider Trades & SAST Disclosures
Susan M. Molineaux's most recent trade in Repare Therapeutics Inc was a trade of 27,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Susan M. Molineaux.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Susan Molineaux M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 6,220 | 130,527 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Susan M. Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 01 May 2023 | 35,000 | 35,000 (0%) | 0% | 1.1 | 38,500 | Common Stock |
| Geron Corp. | Susan M. Molineaux | Director | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 01 May 2023 | 35,000 | 0 (0%) | 0% | 2.5 | 86,800 | Common Stock |
| Geron Corp. | Susan M. Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 35,000 | 0 | - | - | Stock Options (right to buy) | |
| Geron Corp. | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 6,048 | 114,028 (0%) | 0% | 0 | Common Stock | |
| Cyteir Therapeutics Inc | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 14,150 | 14,150 | - | - | Stock Option (Right to Buy) | |
| Cyteir Therapeutics Inc | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 14,150 | 14,150 | - | - | Stock Option (Right to Buy) | |
| Geron Corp. | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| Theravance Biopharma Inc | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 9,828 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) | |
| Geron Corp. | Susan M. Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges